Pell Bio-Med Technology Co., Ltd. (TPE:6949)
Taiwan
· Delayed Price · Currency is TWD 159.50
-1.00 (-0.62%)
Jul 11, 2025, 1:35 PM CST
Pell Bio-Med Technology Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -379.89 | -389.42 | -398.76 | -230.13 | -188.96 |
Depreciation & Amortization | 46.51 | 46.28 | 45.4 | 30.38 | 29.28 |
Other Amortization | 0.46 | 0.6 | 0.22 | 0.66 | 0.88 |
Loss (Gain) From Sale of Assets | - | 0.14 | 0.13 | - | 0.2 |
Loss (Gain) From Sale of Investments | -5.07 | 0.62 | - | - | - |
Loss (Gain) on Equity Investments | -0.22 | -0.11 | -0.11 | 0 | -0.01 |
Stock-Based Compensation | 41.38 | 58.97 | 143.06 | 46.68 | 24.96 |
Provision & Write-off of Bad Debts | - | - | - | 0.07 | - |
Other Operating Activities | -7.43 | -6.8 | -2.98 | -1.15 | - |
Change in Accounts Receivable | 1.87 | 3.85 | -1.56 | -1.62 | -3.39 |
Change in Inventory | -3.48 | -2.42 | 0.82 | -0.34 | 7.15 |
Change in Accounts Payable | -1.46 | -2.53 | 1.42 | 2.42 | -5.07 |
Change in Unearned Revenue | - | - | - | -0.75 | - |
Change in Other Net Operating Assets | 41.27 | 30.69 | 32.37 | -7.2 | 27.13 |
Operating Cash Flow | -266.06 | -260.12 | -179.99 | -160.98 | -107.84 |
Capital Expenditures | -311.87 | -263.79 | -16.49 | -6.5 | -14.48 |
Sale of Property, Plant & Equipment | - | 1 | 3.49 | - | 0.05 |
Sale (Purchase) of Intangibles | -0.19 | -0.19 | - | -2 | - |
Investment in Securities | 787.37 | 228.72 | -402.15 | -536 | 100 |
Other Investing Activities | -63.24 | -61.25 | -4.49 | -6.46 | -1.67 |
Investing Cash Flow | 412.06 | -95.51 | -419.63 | -550.96 | 83.9 |
Short-Term Debt Issued | - | 200 | - | 5 | - |
Total Debt Issued | 200 | 200 | - | 5 | - |
Short-Term Debt Repaid | - | - | -5 | - | - |
Long-Term Debt Repaid | - | -25.65 | -25.07 | -10.76 | -10.26 |
Total Debt Repaid | -26.53 | -25.65 | -30.07 | -10.76 | -10.26 |
Net Debt Issued (Repaid) | 173.47 | 174.35 | -30.07 | -5.76 | -10.26 |
Issuance of Common Stock | 25.49 | 331.17 | 625.77 | 759.34 | 5.02 |
Repurchase of Common Stock | - | - | -0.8 | - | - |
Other Financing Activities | 109.8 | 109.8 | - | 14.99 | - |
Financing Cash Flow | 308.76 | 615.32 | 594.89 | 768.56 | -5.23 |
Net Cash Flow | 454.77 | 259.69 | -4.73 | 56.62 | -29.17 |
Free Cash Flow | -577.93 | -523.91 | -196.48 | -167.48 | -122.32 |
Free Cash Flow Margin | -2174.61% | -2668.77% | -1089.53% | -976.14% | -875.12% |
Free Cash Flow Per Share | -9.98 | -9.18 | -4.25 | -4.27 | -3.68 |
Cash Interest Paid | 3.15 | 2.26 | 2.56 | 1.36 | 1.52 |
Cash Income Tax Paid | 1.11 | 1.2 | 0.5 | 0 | - |
Levered Free Cash Flow | -445.7 | -388.73 | -53.62 | -86.4 | - |
Unlevered Free Cash Flow | -443.73 | -387.32 | -52.02 | -85.55 | - |
Change in Net Working Capital | -35.9 | -29.25 | -32.82 | 7.21 | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.